Alan S Forman - Net Worth and Insider Trading

Alan S Forman Net Worth

The estimated net worth of Alan S Forman is at least $1 Million dollars as of 2024-05-24. Alan S Forman is the Director of Stemline Therapeutics Inc and owns about 88,298 shares of Stemline Therapeutics Inc (STML) stock worth over $1 Million. Alan S Forman is also the Director of JBG SMITH Properties and owns about 5,000 shares of JBG SMITH Properties (JBGS) stock worth over $70,350. Details can be seen in Alan S Forman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Alan S Forman has not made any transactions after 2022-05-10 and currently still holds the listed stock(s).

Transaction Summary of Alan S Forman

Alan S Forman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alan S Forman owns 3 companies in total, including Stemline Therapeutics Inc (STML) , JBG SMITH Properties (JBGS) , and Acadia Realty Trust (AKR) .

Click here to see the complete history of Alan S Forman’s form 4 insider trades.

Insider Ownership Summary of Alan S Forman

Ticker	Comapny	Transaction Date	Type of Owner
STML	Stemline Therapeutics Inc	2020-06-10	director
JBGS	JBG SMITH Properties	2022-05-10	director
AKR	Acadia Realty Trust	2005-05-18	director

Alan S Forman Latest Holdings Summary

Alan S Forman currently owns a total of 2 stocks. Among these stocks, Alan S Forman owns 88,298 shares of Stemline Therapeutics Inc (STML) as of December 4, 2019, with a value of $1 Million and a weighting of 93.69%. Alan S Forman also owns 5,000 shares of JBG SMITH Properties (JBGS) as of May 10, 2022, with a value of $70,350 and a weighting of 6.31%.

Latest Holdings of Alan S Forman

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
STML	Stemline Therapeutics Inc	2019-12-04	88,298	11.83	1,044,565
JBGS	JBG SMITH Properties	2022-05-10	5,000	14.07	70,350

Holding Weightings of Alan S Forman

Alan S Forman Form 4 Trading Tracker

According to the SEC Form 4 filings, Alan S Forman has made a total of 2 transactions in Stemline Therapeutics Inc (STML) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Stemline Therapeutics Inc is the acquisition of 1,000 shares on December 4, 2019, which cost Alan S Forman around $9,730.

According to the SEC Form 4 filings, Alan S Forman has made a total of 1 transactions in JBG SMITH Properties (JBGS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in JBG SMITH Properties is the acquisition of 5,000 shares on May 10, 2022, which cost Alan S Forman around $121,600.

Insider Trading History of Alan S Forman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alan S Forman Trading Performance

GuruFocus tracks the stock performance after each of Alan S Forman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alan S Forman is -25.94%. GuruFocus also compares Alan S Forman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alan S Forman within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Alan S Forman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Alan S Forman

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	6.59
Relative Return to S&P 500(%)	4.58

Alan S Forman Ownership Network

Ownership Network List of Alan S Forman

No Data

Ownership Network Relation of Alan S Forman

Alan S Forman Owned Company Details

What does Stemline Therapeutics Inc do?

Who are the key executives at Stemline Therapeutics Inc?

Alan S Forman is the director of Stemline Therapeutics Inc. Other key executives at Stemline Therapeutics Inc include Chief Operating Officer Kenneth Hoberman , and Chief Medical Officer Eric K Rowinsky .

Stemline Therapeutics Inc (STML) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Stemline Therapeutics Inc (STML) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Stemline Therapeutics Inc (STML) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Stemline Therapeutics Inc (STML)'s detailed insider trading history can be found in Insider Trading Tracker table.

Stemline Therapeutics Inc Insider Transactions

No Available Data

What does JBG SMITH Properties do?

Who are the key executives at JBG SMITH Properties?

Alan S Forman is the director of JBG SMITH Properties. Other key executives at JBG SMITH Properties include director & Executive Vice Chairman Robert Alexander Stewart , EVP & HEAD OF CAPITAL MARKETS Madhumita Moina Banerjee , and Chief Accounting Officer Angela Valdes .

JBG SMITH Properties (JBGS) Insider Trades Summary

Over the past 18 months, Alan S Forman made no insider transaction in JBG SMITH Properties (JBGS). Other recent insider transactions involving JBG SMITH Properties (JBGS) include a net sale of 58,652 shares made by Madhumita Moina Banerjee , a net purchase of 30,000 shares made by Robert Alexander Stewart , and a net sale of 16,000 shares made by Kevin Reynolds .

In summary, during the past 3 months, insiders sold 16,901 shares of JBG SMITH Properties (JBGS) in total and bought 30,000 shares, with a net purchase of 13,099 shares. During the past 18 months, 87,214 shares of JBG SMITH Properties (JBGS) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 57,214 shares.

JBG SMITH Properties (JBGS)'s detailed insider trading history can be found in Insider Trading Tracker table.

JBG SMITH Properties Insider Transactions

No Available Data

What does Acadia Realty Trust do?

Who are the key executives at Acadia Realty Trust?

Alan S Forman is the director of Acadia Realty Trust. Other key executives at Acadia Realty Trust include Senior Vice President/CFO John J. Gottfried , Senior Vice President Richard Hartmann , and Sr. Vice President Joseph Napolitano .

Acadia Realty Trust (AKR) Insider Trades Summary

Over the past 18 months, Alan S Forman made no insider transaction in Acadia Realty Trust (AKR). Other recent insider transactions involving Acadia Realty Trust (AKR) include a net sale of 103,565 shares made by Joseph Napolitano , a net sale of 25,000 shares made by John J. Gottfried , and a net purchase of 1,700 shares made by C David Zoba .

In summary, during the past 3 months, insiders sold 87,025 shares of Acadia Realty Trust (AKR) in total and bought 1,000 shares, with a net sale of 86,025 shares. During the past 18 months, 162,172 shares of Acadia Realty Trust (AKR) were sold and 60,950 shares were bought by its insiders, resulting in a net sale of 101,222 shares.

Acadia Realty Trust (AKR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Acadia Realty Trust Insider Transactions

No Available Data

Alan S Forman Mailing Address

Above is the net worth, insider trading, and ownership report for Alan S Forman. You might contact Alan S Forman via mailing address: 55 Whitney Avenue, 5th Floor, New Haven Ct 06511.

Discussions on Alan S Forman

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.